Progyny Inc has a consensus price target of $46.38 based on the ratings of 14 analysts. The high is $81 issued by Berenberg on September 30, 2021. The low is $30 issued by Barclays on May 13, 2024. The 3 most-recent analyst ratings were released by JMP Securities, Truist Securities, and Cantor Fitzgerald on July 16, 2024, May 17, 2024, and May 16, 2024, respectively. With an average price target of $40.33 between JMP Securities, Truist Securities, and Cantor Fitzgerald, there's an implied 45.14% upside for Progyny Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/16/2024 | Buy Now | 29.54% | JMP Securities | Constantine Davides | → $36 | Initiates | → Market Outperform | Get Alert |
05/17/2024 | Buy Now | 33.14% | Truist Securities | Jailendra Singh | $46 → $37 | Maintains | Buy | Get Alert |
05/16/2024 | Buy Now | 72.72% | Cantor Fitzgerald | Sarah James | → $48 | Reiterates | Overweight → Overweight | Get Alert |
05/13/2024 | Buy Now | 7.95% | Barclays | Sarah James | $48 → $30 | Maintains | Overweight | Get Alert |
05/10/2024 | Buy Now | 33.14% | Canaccord Genuity | Richard Close | $46 → $37 | Maintains | Buy | Get Alert |
05/10/2024 | Buy Now | 47.54% | BTIG | David Larsen | $50 → $41 | Maintains | Buy | Get Alert |
05/10/2024 | Buy Now | — | Keybanc | Scott Schoenhaus | — | Downgrade | Overweight → Sector Weight | Get Alert |
04/17/2024 | Buy Now | 65.53% | Truist Securities | Jailendra Singh | $46 → $46 | Reiterates | Buy → Buy | Get Alert |
02/28/2024 | Buy Now | 72.72% | Cantor Fitzgerald | Sarah James | → $48 | Reiterates | Overweight → Overweight | Get Alert |
02/28/2024 | Buy Now | 65.53% | Truist Securities | Jailendra Singh | $47 → $46 | Maintains | Buy | Get Alert |
02/28/2024 | Buy Now | 54.73% | Keybanc | — | $45 → $43 | Maintains | Overweight | Get Alert |
02/26/2024 | Buy Now | 76.32% | Leerink Partners | Michael Cherny | → $49 | Initiates | → Outperform | Get Alert |
11/08/2023 | Buy Now | 69.13% | Truist Securities | Jailendra Singh | $52 → $47 | Maintains | Buy | Get Alert |
11/08/2023 | Buy Now | 61.93% | Keybanc | Scott Schoenhaus | $50 → $45 | Maintains | Overweight | Get Alert |
10/09/2023 | Buy Now | 105.11% | JP Morgan | Anne Samuel | $58 → $57 | Maintains | Overweight | Get Alert |
09/27/2023 | Buy Now | 65.53% | Canaccord Genuity | Richard Close | → $46 | Initiates | → Buy | Get Alert |
09/14/2023 | Buy Now | 72.72% | Cantor Fitzgerald | Sarah James | $45 → $48 | Maintains | Overweight | Get Alert |
08/11/2023 | Buy Now | 87.12% | Truist Securities | Jailendra Singh | $48 → $52 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 79.92% | Keybanc | Scott Schoenhaus | $45 → $50 | Maintains | Overweight | Get Alert |
05/22/2023 | Buy Now | 79.92% | BTIG | David Larsen | → $50 | Initiates | → Buy | Get Alert |
05/15/2023 | Buy Now | 108.71% | JP Morgan | Anne Samuel | $61 → $58 | Maintains | Overweight | Get Alert |
05/09/2023 | Buy Now | 79.92% | B of A Securities | Michael Cherny | $40 → $50 | Maintains | Buy | Get Alert |
05/09/2023 | Buy Now | 61.93% | Cantor Fitzgerald | Sarah James | $44 → $45 | Maintains | Overweight | Get Alert |
04/21/2023 | Buy Now | 58.33% | Cantor Fitzgerald | Sarah James | → $44 | Initiates | → Overweight | Get Alert |
01/05/2023 | Buy Now | 22.35% | SVB Leerink | Stephanie Davis | $59 → $34 | Downgrade | Outperform → Market Perform | Get Alert |
12/19/2022 | Buy Now | 61.93% | Keybanc | Scott Schoenhaus | $55 → $45 | Maintains | Overweight | Get Alert |
11/18/2022 | Buy Now | 123.1% | JP Morgan | Anne Samuel | $78 → $62 | Maintains | Overweight | Get Alert |
09/16/2022 | Buy Now | 97.91% | Keybanc | Scott Schoenhaus | → $55 | Maintains | Overweight | Get Alert |
09/07/2022 | Buy Now | 101.51% | Truist Securities | Jailendra Singh | → $56 | Initiates | → Buy | Get Alert |
12/02/2021 | Buy Now | 115.91% | Jefferies | Glen Santangelo | — | Initiates | → Buy | Get Alert |
09/30/2021 | Buy Now | 191.47% | Berenberg | — | — | Initiates | → Buy | Get Alert |
09/28/2021 | Buy Now | 187.87% | Barclays | Sarah James | — | Maintains | Overweight | Get Alert |
08/25/2021 | Buy Now | 159.09% | Barclays | Sarah James | — | Maintains | Overweight | Get Alert |
08/12/2021 | Buy Now | 130.3% | Barclays | Sarah James | — | Initiates | → Overweight | Get Alert |
08/06/2021 | Buy Now | 112.31% | SVB Leerink | Stephanie Davis | — | Maintains | Outperform | Get Alert |
The latest price target for Progyny (NASDAQ:PGNY) was reported by JMP Securities on July 16, 2024. The analyst firm set a price target for $36.00 expecting PGNY to rise to within 12 months (a possible 29.54% upside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for Progyny (NASDAQ:PGNY) was provided by JMP Securities, and Progyny initiated their market outperform rating.
There is no last upgrade for Progyny
The last downgrade for Progyny Inc happened on May 10, 2024 when Keybanc changed their price target from N/A to N/A for Progyny Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Progyny, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Progyny was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
While ratings are subjective and will change, the latest Progyny (PGNY) rating was a initiated with a price target of $0.00 to $36.00. The current price Progyny (PGNY) is trading at is $27.79, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.